Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | POLB | P06746 | 3/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18009466 | 0.84 | SMN1; SMN2 (0.34) | SMN1; SMN2ALDH1A1POLBCYP1A2CYP3A4 | |
| SCHEMBL18009397 | 0.84 | ALDH1A1 (0.37) | SMN1; SMN2ALDH1A1POLBCYP1A2CYP3A4 | |
| SCHEMBL18009208 | 0.79 | HCAR2 (0.35) | — | |
| SCHEMBL18007446 | 0.78 | HRH3 (0.38) | SMN1; SMN2ALDH1A1POLB | |
| SCHEMBL18009330 | 0.78 | HRH3 (0.38) | SMN1; SMN2ALDH1A1POLB | |
| SCHEMBL18009209 | 0.74 | KEAP1 (0.31) | ALDH1A1L3MBTL1ATM | |
| SCHEMBL18007453 | 0.73 | — | — | |
| SCHEMBL18009213 | 0.71 | GLA (0.36) | SMN1; SMN2ALDH1A1POLBL3MBTL1LMNA | |
| SCHEMBL18009340 | 0.71 | GLA (0.36) | SMN1; SMN2ALDH1A1POLBL3MBTL1LMNA | |
| SCHEMBL18009338 | 0.69 | PKM (0.34) | SMN1; SMN2ALDH1A1POLBCYP3A4PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016127186-A1 | FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE | NGUYEN MARK QUANG (US) | 2016-08-11 | — | — | WO | disclosed |